The founders detailed how their startup is developing AI that can design chips, learn from each iteration, and improve ...

Currently, the term "RSI (Recursive Self-Improvement)" is attracting attention in the AI industry.AI rewrites its own code, ...

As AI companies warn of the dangers of self-improving AI, a new report offers a rare look at how they’re working to make it a ...

How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...

Since I called it three times in the recursion, the return process also happens three times. Even though I understood it in ...

The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $4.63, representing a -3.14% change from its previous ...

Tempus and Recursion deepen their partnership with a new license agreement for Recursion’s RNA Foundation Model, following a $42 million commitment to data collaboration.

Recursion Pharmaceuticals (RXRX) is back on traders’ screens after a sharp daily move, with the share price closing at US$3.83. Recent returns have been mixed over the past week and month. For context ...

Recursive self-improvement could allow AI systems to design and build powerful versions of themselves, potentially accelerating progress toward superintelligent AI.

Artificial intelligence (AI) has made groundbreaking strides in recent years, yet achieving true self-evolution—an AI ...